Importance of Amino Acids of the Central Portion of the Second Intracellular Loop of the Gastrin-Releasing Peptide Receptor for Phospholipase C Activation, Internalization, and Chronic Down-Regulation

Little is known about the function of the central portion of the second intracellular loop (i2 loop) of peptide receptors in activation of downstream pathways and receptor modulatory processes such as receptor internalization or chronic down-regulation (DR). Recent data suggest a role for i2 loop hydrophobic amino acids in these processes. We used site-directed mutagenesis to address these issues with the gastrin-releasing peptide receptor (GRP-R). Each i2 loop residue from 142 to 148 was mutated and the receptors were expressed in Balb 3T3 cells. Two mutants showed a minimal (<2-fold) decrease in affinity. Five mutants showed decreased efficacy for activating phospholipase C (PLC). Two double mutants (IM143.147AA and VM144.147AA) showed a minimal decrease in affinity but had a decreased ability to fully activate PLC. Only the IM double mutation had decreased maximal internalization, whereas the R145A single mutant showed an increase, suggesting a tonic inhibitory role for Arg-145 in internalization. Three single and both double mutants showed decreases in receptor DR. There was a weak correlation between the extent of GRP-R internalization and the maximal PLC activation, whereas changes in the maximal PLC activation were significantly (p = 0.008) coupled to receptor DR. This study shows that amino acids of the i2 loop of the GRP-R are important in activation of PLC, internalization and down-regulation, but not for affinity. Our results support the proposal that internalization and chronic down-regulation have differing dependence on PLC and are largely independent processes, because some mutants showed no changes in internalization, but significant alterations in down-regulation.

[1]  T. Ferman,et al.  Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. , 2003, Parkinsonism & related disorders.

[2]  Robert J. Lefkowitz,et al.  Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors , 2001, Nature Reviews Neuroscience.

[3]  R. Jensen,et al.  Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* , 2001, The Journal of Biological Chemistry.

[4]  R. Neubig,et al.  ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling. , 2001, American journal of physiology. Cell physiology.

[5]  M. Zastrow.  Endocytosis and downregulation of G protein-coupled receptors. , 2001 .

[6]  T. Spalding,et al.  Constitutively active muscarinic receptors. , 2001, Life sciences.

[7]  Krzysztof Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Science.

[8]  R. Jensen,et al.  Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. , 2000, Molecular pharmacology.

[9]  J. Battey,et al.  Phosphorylation Uncouples the Gastrin-releasing Peptide Receptor from Gq * , 1999, The Journal of Biological Chemistry.

[10]  H. Tai,et al.  Phenylalanine 138 in the second intracellular loop of human thromboxane receptor is critical for receptor-G-protein coupling. , 1999, Biochemical and biophysical research communications.

[11]  J. Wess,et al.  Use of a Disulfide Cross-linking Strategy to Study Muscarinic Receptor Structure and Mechanisms of Activation* , 1999, The Journal of Biological Chemistry.

[12]  M. Brann,et al.  The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling* , 1998, The Journal of Biological Chemistry.

[13]  R. Neubig,et al.  Cotransfection of second and third intracellular loop fragments inhibit angiotensin AT1a receptor activation of phospholipase C in HEK-293 cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[14]  R. Jensen,et al.  Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton. , 1997, Biochemistry.

[15]  J. Edwardson,et al.  Endocytosis and recycling of G protein-coupled receptors. , 1997, Trends in pharmacological sciences.

[16]  W. Sadee,et al.  Residues Specifically Involved in Down‐Regulation but Not Internalization of the m1 Muscarinic Acetylcholine Receptor , 1997, Journal of neurochemistry.

[17]  J. Edwardson,et al.  Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization , 1997, British journal of pharmacology.

[18]  R. Leurs,et al.  Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists. , 1996, The Journal of biological chemistry.

[19]  K. Catt,et al.  Effects of Second Intracellular Loop Mutations on Signal Transduction and Internalization of the Gonadotropin-releasing Hormone Receptor (*) , 1995, The Journal of Biological Chemistry.

[20]  R. T. Jensen,et al.  Mammalian bombesin receptors , 1995, Medicinal research reviews.

[21]  N Blin,et al.  Mapping of Single Amino Acid Residues Required for Selective Activation of G by the m3 Muscarinic Acetylcholine Receptor (*) , 1995, The Journal of Biological Chemistry.

[22]  C. Logsdon,et al.  Influence of Second and Third Cytoplasmic Loops on Binding, Internalization, and Coupling of Chimeric Bombesin/m3 Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.

[23]  Ian Foracs.  Physiology of the Gastrointestinal Tract (3rd ed) , 1995 .

[24]  J. Battey,et al.  The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist (*) , 1995, The Journal of Biological Chemistry.

[25]  R. Jensen,et al.  Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism (*) , 1995, The Journal of Biological Chemistry.

[26]  E. Hulme,et al.  The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor. , 1995, European journal of pharmacology.

[27]  R. Jensen,et al.  Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. , 1994, Molecular pharmacology.

[28]  R. Jensen,et al.  Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. , 1994, Molecular pharmacology.

[29]  R. Jensen,et al.  Desensitization of neuromedin B receptors (NMB-R) on native and NMB-R-transfected cells involves down-regulation and internalization. , 1994, The Journal of biological chemistry.

[30]  B. A. Harris,et al.  Activation of Gi protein by peptide structures of the muscarinic M2 receptor second intracellular loop. , 1994, European journal of pharmacology.

[31]  W. Sadee,et al.  Overlapping multi-site domains of the muscarinic cholinergic Hm1 receptor involved in signal transduction and sequestration. , 1994, The Journal of biological chemistry.

[32]  L. Johnson,et al.  Physiology of the gastrointestinal tract , 2012 .

[33]  G. Bokoch,et al.  Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. Mapping with receptor-derived peptides. , 1994, The Journal of biological chemistry.

[34]  W. Sadee,et al.  Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. , 1993, The Journal of biological chemistry.

[35]  R. Jensen,et al.  Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. , 1993, The Journal of biological chemistry.

[36]  R. Butcher,et al.  Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment. , 1993, Molecular pharmacology.

[37]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[38]  Á. Valverde,et al.  Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. , 1993, The Journal of biological chemistry.

[39]  W. Sadee,et al.  Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. , 1992, The Journal of biological chemistry.

[40]  C. Fraser,et al.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.

[41]  M. Caron,et al.  Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration. , 1991, Molecular pharmacology.

[42]  C. Strader,et al.  Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor. , 1990, Molecular pharmacology.

[43]  J. Brodsky,et al.  Sodium affinity of brain Na(+)-K(+)-ATPase is dependent on isozyme and environment of the pump. , 1990, The American journal of physiology.

[44]  A. Kurosky,et al.  Molecular characterization of bombesin receptors on rat pancreatic acinar AR42J cells. , 1990, The American journal of physiology.

[45]  E. Ross,et al.  Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists. , 1990, The Journal of biological chemistry.

[46]  S. Fisher,et al.  Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. , 1990, The Journal of pharmacology and experimental therapeutics.

[47]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[48]  G. M. Walton,et al.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation , 1989, Cell.

[49]  C. Strader,et al.  Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs. , 1989, Molecular pharmacology.

[50]  Eliot R. Spindel,et al.  Report and Recommendations 14 October 1987 , 1988 .

[51]  E. Rozengurt.  Bombesin‐Induction of Cell Proliferation in 3T3 Cells , 1988, Annals of the New York Academy of Sciences.

[52]  J. Venter,et al.  Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Disease,et al.  Bombesin-like peptides in health and disease , 1988 .

[54]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Ullrich,et al.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing , 1987, Cell.

[56]  C. Strader,et al.  The carboxyl terminus of the hamster β-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration , 1987, Cell.

[57]  R. Tsien,et al.  Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor , 1987, Nature.

[58]  R. Jensen,et al.  Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. , 1982, The Journal of biological chemistry.

[59]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[60]  S. B. Needleman,et al.  A general method applicable to the search for similarities in the amino acid sequence of two proteins. , 1970, Journal of molecular biology.